摘要
目的系统地探究在高血压患者治疗中使用β受体阻滞剂的价值。方法选取我院收治的80例高血压患者,结合临床随机表法将其平均地列入观察组与对照组。对照组与观察组分别使用钙拮抗剂药物苯磺酸氨氯地平与β受体阻滞剂美托洛尔进行治疗,观察两组的疗效。结果观察组的治疗有效率为95.0%,对照组的治疗有效率为80.0%,差异有统计学意义(P<0.05);两组均不存在严重的不良反应。结论在高血压的治疗中,β受体阻滞剂美托洛尔的疗效满意。
Objective To systematically explore the use of Beta-blocker in the treatment of patients with high blood pressure values. Methods Chose 80 cases of our hospital patients with high blood pressure,combined with clinical random table method woubld be devided into observation group and control group. Control group and observation group,respectively used amlodipine and receptor blocker metoprolol for treatment. Observation of the curative effect of two groups. Results The treatment group of effective rate was 95.0%,the control group treatment effective rate was 80.0%,the difference was statistically significant（P〈0.05）. In the two groups were no serious adverse reactions. Conclusion In the treatment of high blood pressure,Betablocker metoprolol has high value.
出处
《中国卫生标准管理》
2016年第6期100-101,共2页
China Health Standard Management
关键词
高血压
Β受体阻滞剂
钙拮抗剂
治疗有效率
不良反应
Hypertension
Beta-blocker
Calcium antagonists
Efficiency of treatment
Adverse reactions
